recombinant FSH

PreclinicalSmall molecule

Ferring

recombinant FSH is one of 93 small molecule programs targeting Ovarian Reserve. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Ovarian ReserveActive, not recruiting

ObesityActive, not recruiting

InfertilityActive, not recruiting

Ovarian ReservePreclinical

Active, not recruiting

ObesityPreclinical

Active, not recruiting

InfertilityPreclinical

Active, not recruiting

Competition

Competitive Landscape

176 competitors in Obesity

#DrugCompanyPhaseTrials

Cagrilintide

Novo Nordisk

Phase 3

9 2

Maridebart Cafraglutide

Amgen

Phase 3

11 3

Retatrutide

Eli Lilly

Phase 3

6 4

Berobenatide

Pfizer

Phase 3

6 5

HRS9531

FFujian Shengdi Pharmaceutical Co., Ltd.

Phase 3

1 6

Naltrexone-Bupropion Combination

CCurrax Pharmaceuticals

Phase 3

2 7

Efsubaglutide Alfa

SShanghai Yinnuo Pharmaceutical Technology Co., Ltd.

Phase 3

1 8

Survodutide

Boehringer Ingelheim

Phase 3

2 9

Actemra

Roche

Preclinical

2 10

Avapro

Sanofi

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2028

PreclinicalActive, not recruiting

Infertility

NCT01421095

Clinical

Trials by Indication[1]

Ovarian Stimulation2 trials

Gonadotropin Type in Ovarian Stimulation

Completed·IIVI Madrid·Phase 4·NCT02437032·100 enrolled

Ovarian Stimulation: Inositol and Melatonin

Withdrawn·AAGUNCO Obstetrics and Gynecology Centre·Phase 4·NCT01267604

Obesity1 trial

Dysregulation of FSH in Obesity: Functional and Statistical Analysis

Completed·UUniversity of Colorado, Denver·N/A·NCT02478775·99 enrolled

Embryo1 trial

Time-lapse Evaluation of Embryo Development After Stimulation With One of Two Different Gonadotrophins.

Terminated·UUniversity of Aarhus·Phase 4·NCT01345812·291 enrolled

CLE1 trial

Comparative Study Between Single Versus Dual Trigger for Poor Responders in GnRH-antagonist ICSI Cycles

Completed·—·Phase 4·NCT04008966·160 enrolled

Frozen Embryo Transfer1 trial

Replacement of Fresh Embryo Transfers (ETs) by Frozen Embryo Transfers (FETs) Using Vitrification

Unknown status·YYazd Research & Clinical Center for Infertility·Phase 1/2·NCT00823121·500 enrolled

11 more indications

Surgery1 trial

Role of FSHR Polymorphism p.N680S in the Therapy With FSH in Patients Who Underwent Varicocele Surgery

Unknown status·UU.O. Chirurgia Andrologica·Phase 4·NCT02719093·100 enrolled

Blastocyst1 trial

MENOPUR® in a Gonadotropin-Releasing Hormone (GnRH) Antagonist Cycle With Single-Blastocyst Transfer in a High Responder Subject Population

Completed· Ferring logo

Ferring·Phase 4·NCT02554279·620 enrolled

Progesterone1 trial

Patients' Preference for Subcutaneous or Vaginal Progesterone as Luteal Support in IVF/ICSI Cycles

Terminated·AAndros Day Surgery Clinic·Phase 4·NCT03181685·60 enrolled

Gonadotrophin-releasing Hormone (GnRH)1 trial

MENOPUR in Gonadotrophin-releasing Hormone (GnRH) Antagonist Cycles With Single Embryo Transfer

Completed· Ferring logo

Ferring·Phase 3·NCT00884221·749 enrolled

Ovarian1 trial

Corifollitropin Alfa Followed by Menotropin for Poor Ovarian Responders Trial

Completed·UUniversitair Ziekenhuis Brussel·Phase 3·NCT01816321·150 enrolled

Pregnancy1 trial

Modified Natural Cycle Offers a Chance of Pregnancy in Patients With Poor Response and High Basal FSH

Completed·EEugonia··NCT00417157·135 enrolled

Ovulation Induction1 trial

Recombinant Follicle Stimulating Hormone (FSH) (Gonal-f®): Use in Ovulation Induction

Completed· Merck & Co. logo

Merck & Co.·Phase 4·NCT01081626·310 enrolled

PCOS1 trial

LOD vs Gn in Anovulatory PCOs Resistant to First Line Agents

Unknown status·—·N/A·NCT04325295·200 enrolled

Oocyte1 trial

Use of Corifolitropin Alfa in Oocyte Donors

Unknown status·IIVI Madrid·Phase 4·NCT02213627·300 enrolled

Infertility1 trial

Ovarian Reserve Testing in Female Young Adult Cancer Survivors

Active, not recruiting·UUniversity of California, San Diego·Preclinical·NCT01421095·34 enrolled

Unspecified1 trial

Multiple Dose FSH-GEX(TM) in Healthy Volunteers

Completed·GGlycotope GmbH·Phase 1·NCT01477073·57 enrolled

Sources

References

[1]
ClinicalTrials.gov — 17 trial records for recombinant FSH. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — recombinant FSH compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for recombinant FSH. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Ferring company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: Ferring

recombinant FSH

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q4 2028

Trials by Indication[1]

Ovarian Stimulation2 trials

Obesity1 trial

Embryo1 trial

CLE1 trial

Frozen Embryo Transfer1 trial

Surgery1 trial

Blastocyst1 trial

Progesterone1 trial

Gonadotrophin-releasing Hormone (GnRH)1 trial

Ovarian1 trial

Pregnancy1 trial

Ovulation Induction1 trial

PCOS1 trial

Oocyte1 trial

Infertility1 trial

Unspecified1 trial

References

Drug Info

Quick Facts

Related News